Journal article
An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease
- Abstract:
-
NP105–113-B*07:02-specific CD8+ T cell responses are considered among the most dominant in SARS-CoV-2-infected individuals. We found strong association of this response with mild disease. Analysis of NP105–113-B*07:02-specific T cell clones and single-cell sequencing were performed concurrently, with functional avidity and antiviral efficacy assessed using an in vitro SARS-CoV-2 infection system, and were correlated with T cell receptor usa...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Funding
John Fell Fund
More from this funder
Bibliographic Details
- Publisher:
- Springer Nature Publisher's website
- Journal:
- Nature Immunology Journal website
- Volume:
- 23
- Pages:
- 50-61
- Publication date:
- 2021-12-01
- Acceptance date:
- 2021-10-26
- DOI:
- EISSN:
-
1529-2916
- ISSN:
-
1529-2908
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
1214619
- Local pid:
- pubs:1214619
- Deposit date:
- 2021-12-01
Terms of use
- Copyright holder:
- Peng et al.
- Copyright date:
- 2021
- Rights statement:
- Copyright © 2021 The Author(s). This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
- Licence:
- CC Attribution (CC BY)
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record